Hetero | Company Profile
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Development
Email & Communication
Keywords & Focus Areas
Hetero
Overview
Hetero is a prominent Indian pharmaceutical company founded in 1993 and headquartered in Hyderabad. It is recognized as the world's largest producer of anti-retroviral (ARV) drugs and operates in over 140 countries across Asia, Europe, North America, South America, Africa, and the Middle East. With a workforce of over 22,000 employees, it reported revenues of approximately $7.1 billion.
The company specializes in manufacturing active pharmaceutical ingredients (APIs) and finished dosage formulations (FDFs), including a wide range of generic pharmaceuticals and branded generics. It also develops biosimilars and offers custom pharmaceutical services, including contract manufacturing and research. Notably, it was the first Indian company to launch a generic version of Remdesivir for COVID-19 treatment. Hetero is committed to providing affordable access to high-quality medicines, particularly in therapeutic areas such as oncology, cardiology, and CNS disorders.
Basic Information
| Industry | pharmaceuticals |
|---|---|
| Founded | 1993 |
| Revenue | 850M |
| Headquarters | Floor 9-11, Tower 30, RMZ Nexity, Sy. No. 83/1, Knowledge City, Raidurg, Hyderabad, Telangana 500081, India |
| Languages | English |
Contact Details
- Phone: +91 40237 04923
- Website: hetero.com
- LinkedIn: linkedin.com/company/hetero
Key Focus Areas & Initiatives
- active pharmaceutical ingredient
- custom pharma services
- biosimilars
- generic medicine
- pharmaceutical manufacturing
- b2b
- partnership collaborations
- world-class manufacturing
- contract research organization
- global health access
- quality control
- drug licensing
- clinical trials
- healthcare innovation
- clinical trial support
- global health partnership
- market expansion
- health equity
- healthcare infrastructure
- pharma export hub
- affordable medicines
- pharmaceutical logistics
- regulatory compliance
- public-private partnerships
- emerging markets
- pharmaceutical manufacturing jv
- global api supplier
- anti-retroviral drugs
- manufacturing facilities
- healthcare access
- biosimilar biologics
- community health programs
- generic medicines
- hiv treatment drugs
- regulatory approvals
- medical supply chain
- life-saving medicines
- covid-19 therapies
- quality assurance
- pharmaceutical exports
- public health
- manufacturing excellence
- quality standards
- drug development
- pharmaceutical r&d
- global supply chain
- drug safety and quality
- healthcare delivery
- low-cost generics
- emergency health response
- global pharma collaboration
- pharmaceutical technology
- access to medicines
- api synthesis
- sustainable pharma manufacturing
- public health impact
- product portfolio
- supply chain logistics
- biosimilar insulin
- emerging market pharma
- anti-retroviral api
- covid-19 treatments
- global health initiatives
- partnerships in pharma
- market access
- low-cost biosimilars
- contract manufacturing
- sustainable pharma practices
- biotechnology
- clinical research
- global manufacturing
- public health partnership
- supply chain management
- medical research
- biosimilar development
- product diversification
- covid-19 antiviral
- environmental sustainability
- covid-19 drug manufacturing
- research and development
- services
- hiv/aids treatment
- pharmaceutical marketing
- product quality management
- pharmaceutical r&d investment
- global distribution
- healthcare
- environmental responsibility
- global presence
- pharmaceutical innovation
- affordable hiv drugs
- healthcare solutions
- pharmaceutical supply chain
- api export
- pharmaceutical innovation hub
- product development
- sustainability
- healthcare affordability
- sustainable manufacturing
- healthcare infrastructure development
- pharmaceutical and medicine manufacturing
- medical innovation
- community health
- sustainable development
- global generics
- custom pharmaceutical services
- r&d excellence
- chronic therapy areas
- sustainable health equity
- co-development partnerships
- global access
- innovative medicines
- high-quality formulations
- market presence
- advanced research
- social responsibility
- health outcomes
- generic formulations
- medicine affordability
- partnership development
- pharmaceutical distribution
- manufacturing capability
- drug availability
- medicines innovation
- healthcare partnerships
- patient-centered care
- therapeutic areas
- research investments
- therapeutics development
- medical needs
- global reach
- health industry leader
- community healthcare
- safety standards
- educational initiatives
- drug production efficiency
- community engagement
- pharmaceutical industry advancements
- sustainable practices
- distribution
- transportation & logistics
- medical
- health care
- health, wellness & fitness
- hospital & health care
- mechanical or industrial engineering
- logistics & supply chain
- research & development
- environmental services
- renewables & environment
- nonprofit organization management
Technologies Used
- Android
- Apache
- Bootstrap Framework
- GoDaddy Hosting
- Google Analytics
- Google Tag Manager
- Microsoft Office 365
- Mobile Friendly
- Outlook